Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
From MaRDI portal
Publication:1743540
DOI10.1007/s10957-018-1218-4zbMath1390.49019OpenAlexW2788404984MaRDI QIDQ1743540
Heinz Schättler, Elzbieta Ratajczyk, Urszula Łedzewicz-Kowalewska
Publication date: 13 April 2018
Published in: Journal of Optimization Theory and Applications (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s10957-018-1218-4
Control/observation systems governed by ordinary differential equations (93C15) Optimality conditions for problems involving ordinary differential equations (49K15)
Related Items (6)
Slow-fast model and therapy optimization for oncolytic treatment of tumors ⋮ Optimal control for a bone metastasis with radiotherapy model using a linear objective functional ⋮ Analysis of a delayed and diffusive oncolytic M1 virotherapy model with immune response ⋮ Global dynamics of reaction-diffusion oncolytic M1 virotherapy with immune response ⋮ A mathematical model for oncolytic virus spread using the telegraph equation ⋮ Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- The role of TNF-\(\alpha\) inhibitor in glioma virotherapy: a mathematical model
- Geometric optimal control. Theory, methods and examples
- Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments
- Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
- Role of optimal control theory in cancer chemotherapy
- On optimal delivery of combination therapy for tumors
- Treatment of glioma with virotherapy and TNF-\(\alpha\) inhibitors: analysis as a dynamical system
- Modeling of cancer virotherapy with recombinant measles viruses
- Singular trajectories and their role in control theory
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- Optimal control for mathematical models of cancer therapies. An application of geometric methods
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- Cellular Immunotherapy for High Grade Gliomas: Mathematical Analysis Deriving Efficacious Infusion Rates Based on Patient Requirements
- A mathematical model for cell cycle-specific cancer virotherapy
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- On the Dynamics of Tumor-Immune System Interactions and Combined Chemo- and Immunotherapy
- ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY
- ANTI-TUMOR IMMUNITY AND TUMOR ANTI-IMMUNITY IN A MATHEMATICAL MODEL OF TUMOR IMMUNOTHERAPY
- Sufficient conditions for optimality for a mathematical model of drug treatment with pharmacodynamics
This page was built for publication: Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
